Effects of RS-1893, a novel cardiotonic agent, on central and peripheral hemodynamics in anesthetized rats.
スポンサーリンク
概要
- 論文の詳細を見る
After the use of two radionuclides in the tracer microspheres technique in the rat was verified, we examined the central and peripheral hemodynamic effects of RS-1893, an orally active cardiotonic agent. An intravenous infusion of RS-1893 at a dose of 3 μg/kg/min gradually decreased blood pressure and increased heart rate and cardiac output. Blood flows in the kidney and stomach were increased. There was no organ in which blood flow was decreased despite the fall in blood pressure. These data suggest that RS-1893 dilates blood vessels in the whole body, especially in the kidney and stomach.
- 公益社団法人 日本薬理学会の論文
著者
-
SADA Toshio
Biological Research Laboratories, R&D Division, Daiichi-Sankyo Co., Ltd.
-
SHIGA Hiroshi
Biological Research Laboratories, Sankyo Co., Ltd.
-
OIZUMI Kiyoshi
Biological Research Laboratories, Sankyo Co., Ltd.
-
MIYAKE Shigeki
Biological Research Laboratories, Sankyo Co., Ltd.
-
KOIKE Hiroyuki
Biological Research Laboratories, Sankyo Co., Ltd.
-
SADA Toshio
Biological Research Laboratories, Sankyo Co., Ltd.
関連論文
- Spironolactone, but not Eplerenone, Impairs Glucose Tolerance in a Rat Model of Metabolic Syndrome
- Effects of RS-1893, a novel cardiotonic agent, on central and peripheral hemodynamics in anesthetized rats.
- Antihypertensive effect of CS-905, a novel dihydropyridine calcium blocker, in conscious hypertensive dogs.